Central Garden Pet (CENT) AI Stock Analysis

204 Followers

Central Garden Pet

(NASDAQ:CENT)

Select Model

Rating:58Neutral

Price Target:$43.00▼(-8.75% Downside)

Action:reiterated

Date:09/07/26

The score reflects stable but unexciting financial performance (improving margins and gradual deleveraging, offset by declining revenue and weakening free cash flow) as the primary driver. Technical indicators weigh on the score due to negative short-term momentum and oversold readings. Valuation is neutral at a mid-range P/E, with no dividend yield data to add support.

Positive Factors

Improved profitabilityImproved gross and net margins show stronger current earnings conversion despite a softer top line. If sustained, better profitability can support reinvestment, strengthen resilience against cost pressure, and provide more flexibility for debt reduction or strategic growth.

Negative Factors

Persistent revenue declineOngoing revenue contraction indicates limited volume and pricing momentum across the portfolio, which can constrain operating leverage and make margin improvement harder to sustain. Continued top-line weakness may also reduce the resources available for reinvestment and strategic expansion.

Central Garden Pet Key Performance Indicators (KPIs)

Operating Income by SegmentMeasures profitability after operating costs for each segment, revealing which parts of the business generate the most earnings, where margins are under pressure from costs or investments, and whether revenue growth is translating into stronger profits.

Chart Insights

Pet is the reliable profit engine with predictable Q2/Q2-like strength, while Garden is far more volatile—big spring/summer gains can flip to quarter losses as weather, mix and promotions bite. Corporate overhead is a steady drag. Management’s strong Q2 margin beat affirms operational leverage, but the Phillips JV (low‑teens revenue shift) plus weather and input‑cost/retailer promo risk could pressure H2 reported operating income before longer‑term benefits materialize.

Data provided by:

The Fly

Central Garden Pet (CENT) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $2.60B
Dividend Yield: ―
Average Volume (3M): 93.78K
Price to Earnings (P/E): 17.4
Beta (1Y): 0.29
Revenue Growth: -1.16%
EPS Growth: 21.79%
Country: US
Employees: 6,000
Sector: Consumer Defensive
Sector Strength: 62
Industry: Packaged Foods

Central Garden Pet Business Overview & Revenue Model

Company Description

Central Garden & Pet Company (“Central”) is a market leader in the U.S. pet and garden industries. The company operates through two reportable segments: Pet and Garden. Its Pet segment offers a broad range of products for dog and cat supplies, includ...

How the Company Makes Money

Central Garden & Pet makes money primarily by manufacturing, sourcing, marketing, and distributing branded and private-label consumer products in its two operating segments, generating revenue from product sales to retail and other wholesale customer...

Central Garden Pet Earnings Call Summary

Earnings Call Date:May 06, 2026(Q2-2026)|% Change Since:27.95%|Next Earnings Date:Nov 30, 2026

Earnings Call SentimentPositive

The call presented a largely positive operating and financial picture: record Q2 and first-half results, top-line growth (+9% consolidated), margin expansion, improved adjusted EBITDA, strong segment performance (Pet +5%, Garden +13% in Q2), and a robust balance sheet. Strategic simplification and the Phillips JV position the company to focus on higher-margin branded growth, though the JV will reduce reported revenue in the near term and bring a modest initial EPS headwind. Key risks include weather-dependent sell-through (May is pivotal), input cost inflation (notably urea) that may require future pricing, and a promotional retail environment with some private-label pressure. Overall, the positive operational execution, liquidity, and margin improvement outweigh the near-term headwinds and timing risks.

Positive Updates

Record Quarterly and First-Half Results

Company delivered a record fiscal Q2 and record first half with net sales of $906M, up 9% year-over-year, and record Q2 diluted EPS of $1.28 (net income $79M vs $64M prior year).

Negative Updates

Joint Venture Reduces Reported Revenue and Near-Term EPS Impact

Formation of the Phillips JV will reduce reported revenue in H2 by a low-teens percentage. Management expects initial non-cash purchase accounting and JV start-up dynamics to produce a conservative H2 EPS dilution of ~$0.03–$0.05, with benefits expected over time.

Company Guidance

Central reiterated its Fiscal 2026 non‑GAAP diluted EPS guidance of $2.70 or better, supported by a strong Q2 that included net sales of $906M (+9% YoY), gross profit of $300M and a 33.1% gross margin (+30 bps), operating income of $114M (12.6% margin), net income of $79M, diluted EPS of $1.28, and adjusted EBITDA of $139M (15.4% margin), and by a first‑half showing of sales +2%, gross margin +70 bps and operating income +8%; they noted the recently announced JV will lower reported H2 revenue by a low‑teens percentage (with an initial conservative EPS headwind of $0.03–$0.05 in H2 and minimal long‑term earnings impact), CapEx is expected to be ~$50–$60M for the year (Q2 CapEx $10M, D&A $21M), cash & short‑term investments totaled $653M, total debt $1.2B, gross leverage was 2.8x (below their 3.0–3.5x target) and net leverage ~1.3x, and the guidance excludes impacts from future acquisitions, divestitures or restructurings.

Central Garden Pet Financial Statement Overview

Summary

Stable-to-adequate fundamentals: revenue is modestly declining in TTM (-2.48%) and free cash flow fell sharply (~-27.6%), but gross and net margins improved versus 2023–2024 (gross ~32.5%, net ~5.4%). Leverage is moderate and improving (debt-to-equity ~0.81) with steady ROE (~10%), though the absolute debt load remains meaningful. KPI insights point to notable seasonality and volatility (Garden swings and Pet softness), with rising corporate overhead pressuring consolidated margins.

Income Statement

64Positive

Balance Sheet

63Positive

Cash Flow

60Neutral

Financial statement breakdown
Breakdown	TTM	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	3.08B	3.13B	3.20B	3.31B	3.34B	3.30B
Gross Profit	1.00B	972.84M	943.74M	946.84M	992.30M	970.90M
EBITDA	348.67M	359.34M	290.76M	307.17M	338.11M	325.63M
Net Income	166.31M	162.84M	107.98M	125.64M	152.15M	151.75M
Balance Sheet
Total Assets	3.79B	3.63B	3.55B	3.38B	3.28B	3.12B
Cash, Cash Equivalents and Short-Term Investments	996.71M	882.49M	753.55M	488.73M	177.44M	426.42M
Total Debt	1.41B	1.44B	1.42B	1.37B	1.38B	1.36B
Total Liabilities	2.04B	2.04B	2.00B	1.93B	1.95B	1.89B
Stockholders Equity	1.75B	1.58B	1.56B	1.45B	1.33B	1.22B
Cash Flow
Free Cash Flow	345.63M	291.09M	351.76M	327.67M	-149.24M	170.51M
Operating Cash Flow	390.32M	332.51M	394.89M	381.63M	-34.03M	250.84M
Investing Cash Flow	-71.81M	-44.89M	-105.19M	-34.58M	-142.98M	-899.36M
Financing Cash Flow	-32.70M	-156.64M	-25.44M	-37.55M	-66.81M	420.48M

Central Garden Pet Technical Analysis

Technical Analysis SentimentPositive

Last Price47.13

Price Trends

50DMA42.43Positive

100DMA43.11Positive

200DMA40.60Positive

Market Momentum

MACD1.61Negative

RSI62.45Neutral

STOCH53.85Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CENT, the sentiment is Positive. The current price of 47.13 is above the 20-day moving average (MA) of 45.72, above the 50-day MA of 42.43, and above the 200-day MA of 40.60, indicating a bullish trend. The MACD of 1.61 indicates Negative momentum. The RSI at 62.45 is Neutral, neither overbought nor oversold. The STOCH value of 53.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CENT.

Central Garden Pet Risk Analysis

Central Garden Pet disclosed 33 risk factors in its most recent earnings report. Central Garden Pet reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.The adoption of new tax legislation, unanticipated changes in our tax provisions, or exposure to additional tax liabilities could affect our profitability and cash flows.Q3, 2024

2.If we are unable to execute on our Cost and Simplicity Program, our ability to maintain or grow margins may be negatively impacted.Q3, 2024

3.We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, which may result in material misstatements or otherwise adversely affect the accuracy, reliability or timeliness of our financial statements.Q3, 2023

Central Garden Pet Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

CENT against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FRPT	80Outperform	$3.12B	23.98	10.65%	―	11.75%	6.27%
SJM	64Neutral	$14.21B	61.52	4.06%	3.37%	5.08%	―
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
CENT	58Neutral	$2.62B	17.40	10.15%	―	-1.16%	21.79%
GIS	48Neutral	$18.29B	-20.49	-10.69%	7.28%	-4.49%	-131.46%

* Consumer Defensive Sector Average

Performance Comparison

CENT and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CENT	Central Garden & Pet	47.13	15.43	48.71%
GIS	General Mills Inc	33.52	-10.83	-24.42%
SJM	J.M. Smucker Company	131.71	25.83	24.40%
FRPT	Freshpet Inc	64.63	11.19	20.94%

Central Garden Pet Corporate Events

Business Operations and StrategyM&A Transactions

Central Garden & Pet to Acquire Majority of TRIXIE

Positive

Jul 27, 2026

On July 27, 2026, Central Garden & Pet announced a definitive agreement to acquire approximately 80% of TRIXIE Heimtierbedarf, Europe’s leading pet supplies and pet snacks company, for up to €400 million, including about €340 million in cash at closi...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026

Central Garden Pet AI Stock Analysis